GILEAD SCIENCES, INC. Payments to Acquire Other Investments
GILEAD SCIENCES, INC. (GILD) reported Payments to Acquire Other Investments of $35.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherInvestments · last filed 2026-08-06
- GILEAD SCIENCES, INC. payments to acquire other investments for the quarter ending 2026-06-30 was $16.00M, a 23.81% decline year-over-year.
- GILEAD SCIENCES, INC. payments to acquire other investments for the quarter ending 2026-03-31 was $19.00M, a 18.75% increase year-over-year.
- GILEAD SCIENCES, INC. payments to acquire other investments for the quarter ending 2025-12-31 was $14.00M, a 64.10% decline year-over-year.
- GILEAD SCIENCES, INC. payments to acquire other investments for the quarter ending 2025-09-30 was $82.00M, a 811.11% increase year-over-year.
- GILEAD SCIENCES, INC. payments to acquire other investments for fiscal 2025 was $133.00M, a 72.97% decline from fiscal 2024.
- GILEAD SCIENCES, INC. payments to acquire other investments for fiscal 2024 was $492.00M, a 11.31% increase from fiscal 2023.
- GILEAD SCIENCES, INC. payments to acquire other investments for fiscal 2023 was $442.00M, a 156.98% increase from fiscal 2022.
- GILEAD SCIENCES, INC. payments to acquire other investments for fiscal 2022 was $172.00M, a 54.74% decline from fiscal 2021.
| Period end | Payments to Acquire Other Investments 3 month | Payments to Acquire Other Investments 6 month | Payments to Acquire Other Investments 9 month | Payments to Acquire Other Investments 12 month | Payments to Acquire Other Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $16.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $35.00M 10-Q · filed 2026-08-06 | $49.00M derived: sum of 3 quarters · filed 2026-08-06 | $131.00M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $19.00M 10-Q · filed 2026-05-07 | $33.00M derived: sum of 2 quarters · filed 2026-05-07 | $115.00M derived: sum of 3 quarters · filed 2026-05-07 | $136.00M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $96.00M derived: sum of 2 quarters · filed 2026-02-24 | $117.00M derived: sum of 3 quarters · filed 2026-08-06 | $133.00M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $82.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $103.00M derived: sum of 2 quarters · filed 2026-08-06 | $119.00M 10-Q · filed 2025-11-07 | $158.00M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $37.00M 10-Q · filed 2026-08-06 | $76.00M derived: sum of 3 quarters · filed 2026-08-06 | $85.00M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $16.00M 10-Q · filed 2026-05-07 | $55.00M derived: sum of 2 quarters · filed 2026-05-07 | $64.00M derived: sum of 3 quarters · filed 2026-05-07 | $98.00M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $48.00M derived: sum of 2 quarters · filed 2026-02-24 | $82.00M derived: sum of 3 quarters · filed 2026-02-24 | $492.00M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $43.00M derived: sum of 2 quarters · filed 2025-11-07 | $453.00M 10-Q · filed 2025-11-07 | $677.00M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $34.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $444.00M 10-Q · filed 2025-08-07 | $668.00M derived: sum of 3 quarters · filed 2026-02-24 | $694.00M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $410.00M 10-Q · filed 2025-05-07 | $634.00M derived: sum of 2 quarters · filed 2026-02-24 | $660.00M derived: sum of 3 quarters · filed 2026-02-24 | $727.00M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | $224.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $250.00M derived: sum of 2 quarters · filed 2026-02-24 | $317.00M derived: sum of 3 quarters · filed 2026-02-24 | $442.00M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $93.00M derived: sum of 2 quarters · filed 2024-11-12 | $218.00M 10-Q · filed 2024-11-12 | $224.00M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $67.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $192.00M 10-Q · filed 2024-08-08 | $198.00M derived: sum of 3 quarters · filed 2025-02-28 | $320.00M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $125.00M 10-Q · filed 2024-05-08 | $131.00M derived: sum of 2 quarters · filed 2025-02-28 | $253.00M derived: sum of 3 quarters · filed 2025-02-28 | $269.00M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $128.00M derived: sum of 2 quarters · filed 2025-02-28 | $144.00M derived: sum of 3 quarters · filed 2025-02-28 | $172.00M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $122.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $138.00M derived: sum of 2 quarters · filed 2023-11-07 | $166.00M 10-Q · filed 2023-11-07 | $214.00M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2022-06-30 | $16.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $44.00M 10-Q · filed 2023-08-04 | $92.00M derived: sum of 3 quarters · filed 2024-02-23 | $123.00M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2022-03-31 | $28.00M 10-Q · filed 2023-05-03 | $76.00M derived: sum of 2 quarters · filed 2024-02-23 | $107.00M derived: sum of 3 quarters · filed 2024-02-23 | $129.00M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2021-12-31 | $48.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $79.00M derived: sum of 2 quarters · filed 2024-02-23 | $101.00M derived: sum of 3 quarters · filed 2024-02-23 | $380.00M 10-K · filed 2024-02-23 | |
| 2021-09-30 | $31.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $53.00M derived: sum of 2 quarters · filed 2022-11-02 | $332.00M 10-Q · filed 2022-11-02 | $399.00M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-30 | $22.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $301.00M 10-Q · filed 2022-08-08 | $368.00M derived: sum of 3 quarters · filed 2023-02-22 | $670.00M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-31 | $279.00M 10-Q · filed 2022-05-04 | $346.00M derived: sum of 2 quarters · filed 2023-02-22 | $648.00M derived: sum of 3 quarters · filed 2023-02-22 | $726.00M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-31 | $67.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $369.00M derived: sum of 2 quarters · filed 2023-02-22 | $447.00M derived: sum of 3 quarters · filed 2023-02-22 | $455.00M 10-K · filed 2023-02-22 | |
| 2020-09-30 | $302.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $380.00M derived: sum of 2 quarters · filed 2021-11-03 | $388.00M 10-Q · filed 2021-11-03 | $910.00M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-06-30 | $78.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $86.00M 10-Q · filed 2021-08-05 | $608.00M derived: sum of 3 quarters · filed 2022-02-23 | $1.75B derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-03-31 | $8.00M 10-Q · filed 2021-05-06 | $530.00M derived: sum of 2 quarters · filed 2022-02-23 | $1.68B derived: sum of 3 quarters · filed 2022-02-23 | $1.73B derived: sum of 4 quarters · filed 2022-02-23 | |
| 2019-12-31 | $522.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.67B derived: sum of 2 quarters · filed 2022-02-23 | $1.72B derived: sum of 3 quarters · filed 2022-02-23 | $1.77B 10-K · filed 2022-02-23 | |
| 2019-09-30 | $1.15B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $1.20B derived: sum of 2 quarters · filed 2020-11-04 | $1.25B 10-Q · filed 2020-11-04 | $1.27B derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $48.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $104.00M 10-Q · filed 2020-08-06 | $128.00M derived: sum of 3 quarters · filed 2021-02-25 | ||
| 2019-03-31 | $56.00M 10-Q · filed 2020-05-06 | $80.00M derived: sum of 2 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $156.00M 10-K · filed 2021-02-25 | $346.00M 10-K · filed 2019-02-26 | ||
| 2018-09-30 | $132.00M 10-Q · filed 2019-11-05 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 | ||||
| 2016-12-31 | $357.00M 10-K · filed 2019-02-26 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 | ||||
| 2014-12-31 | $18.00M 10-K · filed 2017-02-27 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $0.00 derived: sum of 2 quarters · filed 2016-02-24 | $0.00 derived: sum of 3 quarters · filed 2016-02-24 | $0.00 10-K · filed 2016-02-24 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $0.00 derived: sum of 2 quarters · filed 2013-10-31 | $0.00 10-Q · filed 2013-10-31 | $0.00 derived: sum of 4 quarters · filed 2015-02-25 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $0.00 10-Q · filed 2013-08-01 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | $0.00 derived: sum of 4 quarters · filed 2015-02-25 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2015-02-25 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | $0.00 derived: sum of 4 quarters · filed 2015-02-25 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $0.00 derived: sum of 2 quarters · filed 2015-02-25 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | $25.00M 10-K · filed 2015-02-25 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $0.00 derived: sum of 2 quarters · filed 2013-10-31 | $25.00M 10-Q · filed 2013-10-31 | $25.00M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $25.00M 10-Q · filed 2013-08-01 | $25.00M derived: sum of 3 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $25.00M 10-Q · filed 2013-05-08 | $25.00M derived: sum of 2 quarters · filed 2014-02-25 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $0.00 10-K · filed 2014-02-25 | |||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-06 | ||||
| 2010-12-31 | $0.00 10-K · filed 2013-02-27 | ||||
| 2009-12-31 | $0.00 10-K · filed 2010-03-01 | ||||
| 2008-12-31 | $0.00 10-K · filed 2010-03-01 | ||||
| 2007-12-31 | $5.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |